PARI Global   PARI in the Americas   Contact PARI
     
PARI - Specialist in effective inhalation
Home The Lower Airway The Upper Airway
Products Clinical PARI PALS Playground Locate Patient Connection Technology
 
 
 

 Jet Nebulization
PARI LC® Reusable Nebulizers feature the first ever breath-enhanced jet nebulizer design

 MDI and Chamber
Metered Dose Inhaler Technology, Holding Chamber Technology, and VORTEX® Technology - The PARI Advantage



Sections of this website require Adobe Reader and Flash Player

 
 
 
 

MDI (Metered Dose Inhaler) Technology:


A Metered Dose Inhaler, commonly referred to as an MDI, is a common treatment for respiratory symptoms.  An MDI can be used on a daily or as-needed basis.  Medication is stored inside the MDI's canister, which is depressed to release the medication through a specially designed nozzle.  The nozzle breaks the liquid medication into an aerosol optimally sized to reach the lungs.  Traditionally, the medication has been propelled through the nozzle by CFCs (Chlorofluorocarbons), but recent FDA guidelines mandate that manufacturers use the environmentally safe HFA (Hydrofluoroalkane) propellants. 

VORTEX® with Metered Dose Inhaler (MDI)

 

Holding Chamber Technology:


When a physician prescribes an MDI (Metered Dose Inhaler), they will most likely inform the patient about the use of a holding chamber.  When MDI's are used alone, medication delivery relies on patient technique, which is inconsistent and when performed wrong can result in great loss of medication. 

A holding chamber allows the MDI’s aerosol to be suspended on the inside of the chamber for a brief moment, providing more medication available for patient inhalation.  The results have been clinically proven that using holding chambers with MDI's provide more medication for the patient than when using the MDI alone. 

  

Vortex® Technology – The PARI Advantage:


1. The Vortex® features a unique cyclonic inspiratory flow pattern which further enhances aerosol delivery.

2. The non electrostatic walls of the Vortex® do not attract medication, whereas the conventional plastic chambers’ static walls do.  This is very important as MDIs are now formulated with HFA propellants, which have a higher static charge, potentially causing high medication loss in conventional static-charged plastic chambers.

 

3. One of the reasons for the high efficiency of the Vortex lies in the patent-pending Duckbill valve.  PARI’s Duckbill valve is designed to open with minimal inspiratory effort for patients with low tidal volume, ensure a low loss of medication, and close upon expiration so medication does not go back into the chamber.

 

VORTEX® Video

 
Contact PARI   |   About PARI   |   Careers   |   Trademarks   |   Privacy Policy    |   Terms of Use   |   Site Map
 
     


PARI Respiratory Equipment, Inc.   |   Tel: 1.800.FAST.NEB (327.8632) and 1.804.253.7274   |   Fax: 1.800.727.4112   |   Email: ProductInfo@PARI.com
Website Design and Development by PARI Creative Services
© 2008 PARI Respiratory Equipment, Inc. & PARI GmbH